To look at potential cancer-causing pathways that are altered by C19MC overexpression, we performed RNA sequencing on our Hep3B-ZNF331-C19MC-Fusion (referred to as ‘Hep3B-Fusion’) and the Hep3B-SpCas9 (referred to as ‘Hep3B-Cas9’) control cell lines. Here, ZNF331 is linked to cancer.